Tranexamic Acid Therapeutic Cheat Sheet
Tranexamic acid (TXA) is a synthetic lysine derivative that reversibly blocks the lysine-binding site on plasminogen, preventing conversion to plasmin. While originally developed as an antifibrinolytic agent to reduce bleeding, TXA has several downstream effects that make it useful in dermatology, particularly for pigmentary disorders, with emerging evidence in inflammatory disorders as well. TX …
Tranexamic acid (TXA) is a synthetic lysine derivative that reversibly blocks the lysine-binding site on plasminogen, preventing conversion to plasmin. While originally developed as an antifibrinolytic agent to reduce bleeding, TXA has several downstream effects that make it useful in dermatology, particularly for pigmentary disorders, with emerging evidence in inflammatory disorders as well. TX … 
Recent advances in photodermatology have expanded our understanding of how multiple wavelengths across the electromagnetic spectrum contribute to skin damage, aging, pigmentary disorders, and skin cancer risk. While ultraviolet (UV) radiation has traditionally been the primary focus of sun protection, visible light (VL), high-energy visible (HEV) light, infrared (IR) radiation, and even heat have … 
Dr. Cheri Frey recently delivered an insightful lecture on the evolving landscapes of cosmeceuticals and regenerative medicine. Her presentation addressed the complexities of a crowded market, emerging trends like “prejuvenation,” and the unique biological considerations for treating aging in patients with skin of color.
Navigating the Cosmeceutical Landscape
Dr. Frey acknowledged that t … 
Pigmentary sequelae from acne flares can be more distressing to patients than acne itself, according to Brooklyn, N.Y., dermatologist Dr. Hilary Baldwin. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Baldwin, who shares how her treatment approach has changed over the years. Find out if dermatology clinicians should take an acne-first approach or treat hyperpigmenta …